In conclusion, the present study indicated associations of KIR2DS3 with HCC development and the KIR3DL1/HLA-Bw4 pair with freedom from NUCs in HBV patients, although a larger number of cases are required for statistical purposes. Here, KIR3DL1 is linked to hepatocellular carcinoma.